CoChat

Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer?

Garcia-Etienne, Carlos A., Barile, Monica, Gentilini, Oreste D., Botteri, Edoardo, Rotmensz, Nicole, Sagona, Andrea, Farante, Gabriel, Galimberti, Viviana, Luini, Alberto, Veronesi, Paolo, Bonanni, Bernardo · 2009 · Annals of Surgical Oncology

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Background Approximately 10% of patients with breast cancer who are treated with breast-conserving surgery (BCS) develop an ipsilateral-breast tumor recurrence (IBTR). The optimal local therapy for women with BRCA-associated breast carcinoma remains controversial. We report the outcome of BCS in BRCA mutation carriers followed at a single institution. Methods A total of 54 women with BRCA1/2-associated breast cancer treated with BCS and whole breast radiotherapy were matched for age, tumor size, and time of surgery with 162 patients with sporadic breast cancer who had the same treatment between February 1994 and October 2007. Primary end points were cumulative incidence of IBTR and contralateral breast cancer (CBC). Median follow-up was 4 years for both groups. Results Median age was 36 and 37 years for mutation carriers and controls, respectively; mean tumor size was 1.8 cm in carriers and 1.9 cm in controls. Ten-year cumulative incidence of IBTR was 27% for mutation carriers and 4% for sporadic controls (hazard ratio 3.9; 95% confidence interval 1.1-13.8; P = 0.03). Ten-year cumulative incidence of CBC was 25% for mutation carriers and 1% for sporadic controls (P = 0.03). Conclusions Our data suggest that IBTR risk after BCS in BRCA1/2 mutation carriers is increased compared with patients who have sporadic breast cancer. Likewise, the risk of CBC seems to be increased in this group. These risks and the likelihood of developing new primary tumors should be discussed with car…

Overview

Integrity signals

Registry

Crossref · 10.1245/s10434-009-0638-7

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Loman N, Johannsson O, Bendahl PO, Borg A, Ferno M, Olsson H. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer. 1998; 83:310–9. · DOI · Paper page

Cited by

See all 100

Metadata

Authors
Garcia-Etienne, C. A., Barile, M., Gentilini, O. D., Botteri, E., Rotmensz, N., Sagona, A., Farante, G., Galimberti, V., Luini, A., Veronesi, P., & Bonanni, B.
Affiliations
European Institute of Oncology (IT)
Venue
Annals of Surgical Oncology
Published
2009-08-01
Volume
16
Issue
12
Pages
3380-3387
ISSN
  • 1068-9265 (ISSN-L)
  • 1534-4681
OpenAlex
W2092786953
Cited by
100
References
38
Citations by year
2026: 3 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 10 · 2019: 7 · 2018: 2 · 2017: 9 · 2016: 4 · 2015: 6 · 2014: 9 · 2013: 9 · 2012: 11
FWCI
4.68
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Annals of Surgical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Keywords
breast-conserving surgery, BRCA1 mutation carriers, BRCA2 mutation carriers, hereditary breast cancer, ipsilateral breast tumor recurrence, contralateral breast cancer, whole breast irradiation, risk mitigation strategies
MeSH terms
Adult, Breast Neoplasms, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Prospective Studies, Retrospective Studies, Cohort Studies, Mastectomy, Segmental, Survival Rate, Case-Control Studies, Treatment Outcome, Germ-Line Mutation, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Genes, BRCA1, Genes, BRCA2, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer? https://app.cochat.ai/papers/10.1245/s10434-009-0638-7
The paper
Garcia-Etienne, C. A., Barile, M., Gentilini, O. D., Botteri, E., Rotmensz, N., Sagona, A., Farante, G., Galimberti, V., Luini, A., Veronesi, P., & Bonanni, B. (2009). Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer? Annals of Surgical Oncology. https://doi.org/10.1245/s10434-009-0638-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.